Contenu disponible en anglais seulement.
Bulletin de la Bourse
Purpose Healthcare Innovation Yield ETF (HEAL) inscrit à la Bourse de Toronto
14 janvier 2022
Issuer: Purpose Healthcare Innovation Yield ETF (the "Purpose ETF")
| Security | Symbol | Issued and Outstanding Securities | Reserved Securities | Issue Price |
|---|---|---|---|---|
| ETF Units | HEAL | 50,000 | None | C$20.00 |
| Listing category: | Non-Corporate |
| Trading Currency: | CDN$ |
| Transaction: | Initial public offering (the "Offering") of ETF Units |
| Listing date: | January 17, 2022 (as at 5:01 p.m.) in anticipation of closing of the Offering |
| Anticipated closing date: | January 18, 2022 (prior to the opening) |
| Posted for trading date: | January 18, 2022 (at the opening) subject to confirmation of closing of the Offering |
| Other market(s): | None |
| Designated market maker: | National Bank Financial Inc. |
| Security ownership registration: | CDS book based system and Non-Certificated Issue |
| Investor relations: | Vanessa Fiorido Content Marketing Strategist Tel: 416-583-3850 vanessaf@purposeinvest.com - and - Vladimir Tasevski Chief Operating Officer Tel: 416 871-6454 vladt@purposeinvest.com |
| Incorporation: | A mutual fund established as a trust under the laws of the Province of Ontario pursuant to an amended and restated declaration of trust dated as of December 10, 2021. |
| Manager and Trustee: | Purpose Investments Inc. |
| Fiscal year end: | December 31 |
| Nature of business: | Purpose ETF seeks to provide unitholders with exposure to biotechnology and healthcare companies with: (i) the opportunity for capital appreciation; (ii) monthly cash distributions; and (iii) lower volatility of investment portfolio returns when compared to owning the underlying securities of the fund directly. Investments by the fund may be made globally. |
| Transfer agent and registrar: | TSX Trust Company at its principal office in Toronto. |
| Dividends: | The ETF expects to make distributions annually. |
| Sponsorship: | Not applicable |
| Disclosure documents: | Amendment No. 2 dated December 6, 2021 to the simplified prospectus dated October 4, 2021, (the "Prospectus"), as amended by Amendment No. 1 dated October 29, 2021 (together, the "Prospectus") and Amendment No. 2 dated December 6, 2021 to the annual information form dated October 4, 2021, as amended by Amendment No. 1 dated October 29, 2021 (together, the "AIF" and, together with the Prospectus, the "Disclosure Documents") which are available at . Capitalized terms not otherwise defined herein are as defined in the Disclosure Documents. |
| Initial public offering: | 50,000 ETF Units will be issued at a subscription price of C$20.00 per ETF Unit. The ETF Units of the ETF are being issued and sold on a continuous basis and there is no maximum number of ETF Units that may be issued. |
| TSX contact: | Chris Birkett, Managing Director, ÍÃ×ÓÏÈÉú |